Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: Validation in chronic hepatitis C

Journal of Viral Hepatitis

Volumn 19, Issue 4, 2012, Pages 244-253

  Sasso, M ^a   Tengher Barna, I ^b   Ziol, M ^b   Miette, V ^a   Fournier, C ^c   Sandrin, L ^a   Poupon, R ^d   Cardoso, A C ^e   Marcellin, P ^e   Douvin, C ^f   De Ledinghen, V ^g   Trinchet, J C ^h   Beaugrand, M ^h  

^a R and D Department   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c Medical Affairs Department   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e BEAUJON HOSPITAL   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g HAUT LÉVÊQUE HOSPITAL   (France)

^h HÔPITAL JEAN VERDIER   (France)

Author keywords

controlled attenuation parameter (CAP); Fibroscan ; hepatitis C; liver steatosis; vibration controlled transient elastography (VCTE TM)

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONTROLLED ATTENUATION PARAMETER; DIAGNOSTIC ACCURACY; FATTY LIVER; FEMALE; HEPATITIS C; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VALIDATION STUDY;

ADULT; BIOPSY; CLINICAL LABORATORY TECHNIQUES; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84858276083     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01534.x     Document Type: Article

References (57)

1. Leandro G, Mangia A, Hui J, et al. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 2006; 130 (6): 1636-1642.
2. Asselah T, Rubbia-Brandt L, Marcellin P, Negro F,. Steatosis in chronic hepatitis C: why does it really matter? Gut 2006; 55 (1): 123-130. (Pubitemid 41820647)
3. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M,. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med 1988; 27 (2): 142-149.
4. Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132 (2): 112-117. (Pubitemid 30044177)
5. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40 (6): 1387-1395. (Pubitemid 39657013)
6. Poynard T, Ratziu V, McHutchison J, et al. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology 2003; 38 (1): 75-85. (Pubitemid 36775798)
7. Harrison SA, Brunt EM, Qazi RA, et al. Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2005; 3 (6): 604-609. (Pubitemid 40824754)
8. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G,. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33 (6): 1358-1364. (Pubitemid 32496971)
9. Castera L, Hezode C, Roudot-Thoraval F, et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 2003; 52 (2): 288-292. (Pubitemid 36115074)
10. Fartoux L, Chazouilleres O, Wendum D, Poupon R, Serfaty L,. Impact of steatosis on progression of fibrosis in patients with mild hepatitis C. Hepatology 2005; 41 (1): 82-87. (Pubitemid 40066385)
11. Ohata K, Hamasaki K, Toriyama K, et al. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 2003; 97 (12): 3036-3043. (Pubitemid 36676258)
12. Kurosaki M, Hosokawa T, Matsunaga K, et al. Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy. Hepatol Res 2010; 40 (9): 870-877.
13. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97 (10): 2614-2618.
14. Grant A, Neuberger J,. Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology. Gut 1999; 45 (Suppl 4): 1-11.
15. Stauber RE, Lackner C,. Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C. World J Gastroenterol 2007; 13 (32): 4287-4294. (Pubitemid 47381188)
16. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F,. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009; 51 (3): 433-445.
17. Sasso M, Beaugrand M, de Ledinghen V, et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 2010; 36 (11): 1825-1835.
18. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41 (1): 48-54. (Pubitemid 40066382)
19. Nahon P, Kettaneh A, Tengher-Barna I, et al. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol 2008; 49 (6): 1062-1068.
20. de Ledinghen V, Douvin C, Kettaneh A, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2006; 41 (2): 175-179.
21. Marcellin P, Ziol M, Bedossa P, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009; 29 (2): 242-247.
22. Bedossa P, Poynard T,. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24 (2): 289-293. (Pubitemid 26260021)
23. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29 (12): 1705-1713. (Pubitemid 38091720)
24. de Ledinghen V, Vergniol J,. Transient elastography (FibroScan). Gastroenterol Clin Biol 2008; 6 (Suppl 1): 58-67.
25. Sandrin L, Tanter M, Gennisson JL, Catheline S, Fink M,. Shear elasticity probe for soft tissues with 1-D transient elastography. IEEE Trans Ultrason Ferroelectr Freq Control 2002; 49 (4): 436-446. (Pubitemid 34555341)
26. Sakia RM,. The Box-Cox transformation technique: a review. Statistician 1992; 41: 169-178.
27. Hanley JA, McNeil BJ,. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143 (1): 29-36. (Pubitemid 12142173)
28. Steyerberg EW, Bleeker SE, Moll HA, Grobbee DE, Moons KG,. Internal and external validation of predictive models: a simulation study of bias and precision in small samples. J Clin Epidemiol 2003; 56 (5): 441-447. (Pubitemid 36694096)
29. Efron B, Tibshirani R,. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Statistical Sci 1986; 1 (1): 54-75.
30. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD,. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001; 54 (8): 774-781. (Pubitemid 32722180)
31. Obuchowski NA, Goske MJ, Applegate KE,. Assessing physicians' accuracy in diagnosing paediatric patients with acute abdominal pain: measuring accuracy for multiple diseases. Stat Med 2001; 20 (21): 3261-3278. (Pubitemid 33034885)
32. Lambert J, Halfon P, Penaranda G, Bedossa P, Cacoub P, Carrat F,. How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited. Clin Chem 2008; 54 (8): 1372-1378.
33. Maklad NF, Ophir J, Balsara V,. Attenuation of ultrasound in normal liver and diffuse liver disease in vivo. Ultrason Imaging 1984; 6 (2): 117-125. (Pubitemid 14078183)
34. Taylor KJ, Riely CA, Hammers L, et al. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat. Radiology 1986; 160 (1): 65-71. (Pubitemid 16090075)
35. Wilson LS, Robinson DE, Griffiths KA, Manoharan A, Doust BD,. Evaluation of ultrasonic attenuation in diffuse diseases of spleen and liver. Ultrason Imaging 1987; 9 (4): 236-247.
36. Garra BS, Insana MF, Shawker TH, Russell MA,. Quantitative estimation of liver attenuation and echogenicity: normal state versus diffuse liver disease. Radiology 1987; 162 (1 Pt 1): 61-67. (Pubitemid 17001783)
37. Lu ZF, Zagzebski JA, Lee FT,. Ultrasound backscatter and attenuation in human liver with diffuse disease. Ultrasound Med Biol 1999; 25 (7): 1047-1054. (Pubitemid 29408498)
38. Fujii Y, Taniguchi N, Itoh K, et al. A new method for attenuation coefficient measurement in the liver: comparison with the spectral shift central frequency method. J Ultrasound Med 2002; 21 (7): 783-788. (Pubitemid 34743022)
39. Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134 (4): 960-974.
40. Degos F, Perez P, Roche B, et al. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol 2010; 53 (6): 1013-1021.
41. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128 (2): 343-350. (Pubitemid 40439195)
42. Scheuer PJ, Lefkowitch JH,. Liver Biopsy Interpretation. London and Philadelphia: Elsevier Saunders, 2006.
43. Ganne-Carrie N, Ziol M, de Ledinghen V, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44 (6): 1511-1517. (Pubitemid 44953656)
44. Poynard T, Ratziu V, Naveau S, et al. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol 2005; 4 (10): 10.
45. Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6: 33.
46. Clark JM, Brancati FL, Diehl AM,. Nonalcoholic fatty liver disease. Gastroenterology 2002; 122 (6): 1649-1657. (Pubitemid 34533559)
47. Mehta SR, Thomas EL, Bell JD, Johnston DG, Taylor-Robinson SD,. Non-invasive means of measuring hepatic fat content. World J Gastroenterol 2008; 14 (22): 3476-3483.
48. Hepburn MJ, Vos JA, Fillman EP, Lawitz EJ,. The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: a retrospective observational study. BMC Gastroenterol 2005; 5: 14.
49. Lee SS, Park SH, Kim HJ, et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol 2010; 52 (4): 579-585.
50. McPherson S, Jonsson JR, Cowin GJ, et al. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepatol 2009; 51 (2): 389-397.
51. Guiu B, Loffroy R, Hillon P, Petit JM,. Magnetic resonance imaging and spectroscopy for quantification of hepatic steatosis: urgent need for standardization! J Hepatol 2009; 51 (6): 1082-1083; author reply 3-4.
52. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G,. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010; 53 (2): 372-384.
53. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128 (7): 1898-1906. (Pubitemid 40824701)
54. Bedossa P, Carrat F,. Liver biopsy: the best, not the gold standard. J Hepatol 2009; 50 (1): 1-3.
55. El-Badry AM, Breitenstein S, Jochum W, et al. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 2009; 250 (5): 691-697.
56. DiDonato D, Brasaemle DL,. Fixation methods for the study of lipid droplets by immunofluorescence microscopy. J Histochem Cytochem 2003; 51 (6): 773-780. (Pubitemid 36628858)
57. Fukumoto S, Fujimoto T,. Deformation of lipid droplets in fixed samples. Histochem Cell Biol 2002; 118 (5): 423-428. (Pubitemid 35352128)